SOHO Global Health
SOHO Global Health, headquartered in Indonesia, is a prominent player in the pharmaceutical and healthcare industry, specialising in the development and distribution of high-quality medicines and healthcare products. Founded in 2012, the company has rapidly expanded its operations across Southeast Asia, establishing a strong presence in key markets. With a focus on innovative healthcare solutions, SOHO Global Health offers a diverse range of products, including prescription medications, over-the-counter drugs, and nutritional supplements. Their commitment to quality and sustainability sets them apart in a competitive landscape. Recognised for their excellence, the company has achieved significant milestones, including various certifications and partnerships that enhance their market position. As a trusted name in healthcare, SOHO Global Health continues to contribute to the well-being of communities throughout the region.
DitchCarbon Score
How does SOHO Global Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SOHO Global Health's score of 18 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
SOHO Global Health's reported carbon emissions
In 2023, SOHO Global Health reported total carbon emissions of approximately 7,136,260 kg CO2e. This figure includes 9,200 kg CO2e from Scope 1 emissions, primarily from mobile combustion, and 6,000 kg CO2e from Scope 3 emissions, which encompass waste generated in operations and fuel and energy-related activities. Comparatively, in 2022, the total emissions were about 7,810,840 kg CO2e, with Scope 1 emissions at 3,580 kg CO2e and Scope 3 emissions at 4,080 kg CO2e. This indicates a reduction in total emissions of approximately 674,580 kg CO2e year-on-year. Over the past few years, SOHO Global Health has shown a trend of decreasing emissions, with total emissions in 2021 reaching 10,008,050 kg CO2e and in 2020 at 10,099,890 kg CO2e. The company has not set specific reduction targets through the Science Based Targets initiative (SBTi) or other formal climate pledges. The emissions data is not cascaded from any parent company, and all figures are reported directly from SOHO Global Health. The organisation continues to monitor its carbon footprint and is committed to improving its sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 821,950 | 000,000 | 000,000 | 0,000 | 0,000 |
| Scope 2 | - | - | - | - | - |
| Scope 3 | 228,930 | 000,000 | 000,000 | 0,000 | 0,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SOHO Global Health is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
